A decision analysis of long-term lithium treatment and the risk of renal failure (Q27004676)

chronic renal insufficiency

22404233

title

A decision analysis of long-term lithium treatment and the risk of renal failure (English)

0 references

1 reference

21 September 2020

1 reference

13 March 2019

1 reference

4 November 2019

1 reference

21 September 2020

1 reference

5 April 2021

1 reference

inferred from abstract

antimanic agents

1 reference

22404233

suicide prevention

1 reference

U. Werneke

1

0 references

David Taylor

object named as

D. Taylor

series ordinal

4

0 references

Ellinor Salander Renberg

series ordinal

3

object named as

E. Salander Renberg

1 reference

M. Ott

2

1 reference

B. Stegmayr

series ordinal

5

1 reference

language of work or name

1 reference

September 2012

1 reference

Acta Psychiatrica Scandinavica

1 September 2012

6 references

13 March 2019

4 November 2019

29 May 2020

21 September 2020

5 April 2021

6 February 2023

7 references

13 March 2019

4 November 2019

29 May 2020

21 September 2020

5 April 2021

6 February 2023

126

1 reference

issue

3

1 reference

page(s)

186-97

1 reference

Creative Commons Attribution 2.5 Generic

copyright license

6 references

13 March 2019

4 November 2019

29 May 2020

21 September 2020

5 April 2021

on focus list of Wikimedia project

6 February 2023

ScienceSource

0 references

cites work

Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium salts in the treatment of psychotic excitement

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

A Clinician’s Guide to Monitoring Kidney Function in Lithium-Treated Patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Renal failure occurs in chronic lithium treatment but is uncommon

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Association between consistent purchase of anticonvulsants or lithium and suicide risk: a longitudinal cohort study from Denmark, 1995-2001.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium-associated hyperparathyroidism: report of four cases and review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Valproic acid-induced pancreatitis: 16 new cases and a review of the literature

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium-induced nephropathy: Rate of progression and prognostic factors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium: evidence reconsidered

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium use and discontinuation in a health maintenance organization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Hyperparathyroidism and long-term lithium therapy--a cross-sectional study and the effect of lithium withdrawal

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Lithium in mood disorders: increasing evidence base, declining use?

31 May 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Suicide risk in bipolar disorder during treatment with lithium and divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Monitoring of glomerular filtration rate in lithium-treated outpatients--an ambulatory laboratory database surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Utility scores of symptom profiles in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Treatment with antipsychotics and the risk of diabetes in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Adherence to lithium in naturalistic settings: results from a nationwide pharmacoepidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: lithium and nonlithium patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2012.01847.X

Renal insufficiency in long-term lithium treatment

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

Comparison of hemodialysis and peritoneal dialysis--a cost-utility analysis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3440572

An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder

28 November 2018

1 reference

12 December 2020

A control study of the cutaneous side effects of chronic lithium therapy

1 reference

12 December 2020

Cost-utility analysis in depression: the McSad utility measure for depression health states

1 reference

12 December 2020

Lithium and the kidney scare

1 reference

12 December 2020

Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication

1 reference

12 December 2020

Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up

1 reference

12 December 2020

Patient-based utilities for bipolar disorder-related health states

1 reference

12 December 2020

Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide

1 reference

12 December 2020

10.1111/J.1600-0447.2012.01847.X

Identifiers

DOI

1 reference

release_jnf3oskkibczbirb7wbgrogbca

Fatcat ID

0 references

1 reference

1 reference

22404233

1 reference